Atlas Trials

A Study of LY3209590 in Chinese Participants With Type 2 Diabetes Mellitus

Clinical trial NCT05596747 · COMPLETED

Trial details

NCT number
NCT05596747
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2022-11-30
Primary completion
2023-10-10
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.